April 8, 2021 - A second amended consolidated complaint was filed.

March 18, 2021 - The court granted the defendants' motion to dismiss. The plaintiffs were given leave to amend the complaint.

September 11, 2020 - A motion to dismiss the amended consolidated complaint was filed.

July 13, 2020 - An amended consolidated complaint was filed.

April 14, 2020 - The case was transferred to the U.S. District Court for the Northern District of Florida.

December 30, 2019 - An investor in shares of Trulieve Cannabis Corp. (OTC: TCNN) filed a lawsuit in the U.S. District Court for the Eastern District of New York over alleged violations of Federal Securities Laws by Trulieve Cannabis Corp. in connection with certain allegedly false and misleading statements made between September 25, 2018 and December 17, 2019.

Quincy, FL based Trulieve Cannabis Corp., together with its subsidiaries, operates as a medical marijuana company.

On December 17, 2019, a report was releaded detailing problems with Trulieve’s operations. According to the report, the Company’s cannabis cultivation space consists of hoop houses that produce low quality output, its initial licensing process stinks of corruption, it engages in related-party transactions, and there are ties between the Company and an ongoing FBI investigation. The same day, Trulieve Cannabis Corp announced that it is aware of a “short-seller “report released which according to Trulieve Cannabis Corp contained several false, slanderous and misleading statements about Trulieve.

On December 30, 2019, a lawsuit was filed against Trulieve Cannabis Corp. (OTC: TCNN) over alleged securities laws violations. Shares of Trulieve Cannabis Corp. (OTC: TCNN) declined from $13.57 per share on December 5, 2019 to as low as $9.85 per share on January 8, 2020.

Then on January 10,2020, Trulieve Cannabis Corp. announced that it has filed a lawsuit in Florida state court against the company that released the report on December 17, 2019 alleging, among other claims, defamation for publicly disseminating false and libelous statements about Trulieve to manipulate the stock price and further its own financial interests. Shares of Trulieve Cannabis Corp. (OTC: TCNN) closed on January 13, 2020 at $10.24 per share.

According to the complaint the plaintiff alleges on behalf of purchasers of Trulieve Cannabis Corp. (OTC: TCNN) common shares between September 25, 2018 and December 17, 2019, that the defendants violated Federal Securities Laws.

More specifically, the plaintiff claims that between September 25, 2018 and December 17, 2019, the defendants made false and/or misleading statements and/or failed to disclose that Trulieve overstated its mark-up on its biological assets, that therefore, Trulieve’s reported gross profit was inflated, that Trulieve engaged in an undisclosed related party real estate sale with Defendant Rivers’ husband, and that as a result, defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.